Pimavanserin FDA approval date

The FDA approved Pimavanserin (Nuplazid) on 29 Apr 2016.

FDA approval date
29 Apr 2016

Drug identity checked against registry records

Also recorded as Nuplazid

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-04-29DayPimavanserinFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207318", "applicant_as_listed_by_fda": "ACADIA PHARMS INC", "brand_names": ["NUPLAZID"], "active_ingredients": ["PIMAVANSERIN TARTRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160429", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026